The Hemodialysis Patient and Hand Amputation

2001 ◽  
Vol 21 (6) ◽  
pp. 498-501 ◽  
Author(s):  
Max P. Levine
2016 ◽  
Vol 22 ◽  
pp. 249-250
Author(s):  
Giovanna Rodriguez ◽  
Helena Guber ◽  
Esfandiar Sarfaraz ◽  
Michael Axelrod ◽  
Susan Corcoran
Keyword(s):  

2017 ◽  
Vol 3 (2) ◽  
Author(s):  
Nia Agustiningsih ◽  
Setyawati Soeharto ◽  
Rinik Eko Kapti

Abstract : Patient with chronical diease such as Hemodialysis more likely need psycotherapy because until now medical atention only focus on physical aspect. Psycotherapy that can be used on Hemodialysis that going through depression is cognitive therapy and logo therapy. This study was to analysed the difference of influence between cognitive therapy and logo therapy on Hemodialysis patient that going through depression. This study was used quasi experimental pre–post test design. Respondent taking part in this study was 15 respondent for cognitive therapy and 15 respondent for logo therapy with puporsive sampling procedure. Study was conducted on Hemodialysis unit on RS Wava Husada Kepanjen from 21 April until 26 Mey 2017. Data analysis used on this study was dependent t test  and independent t test. Dependent t test  analysis showed  significant value is 0,000 (less than < 0,05).Analysis showed  significant value is 0,000 (less than < 0,05) that means there is difference between cognitive therapy and logo therapy to decrease depression on hemodialysis patient with mean value cognitive therapy (1,62) dan logo therapy (3,82). Conclussion on this study is that logo therapy more effective to reduce depression on Hemodialysis patient than cognitive therapy so logo therapy can applicated in hemodialysis patient.Keyword : cognitive therapy, logo therapy, depression in hemodialysis patient Abstrak : Pasien dengan penyakit kronis dengan hemodialisis diperlukan psikoterapi karena selama ini fokus penanganan di pelayanan kesehatan hanya pada masalah fisik. Psikoterapi yang bisa digunakan pada pasien hemodialisis yang mengalami depresi adalah cognitive therapy dan logo therapy. Penelitian ini bertujuan untuk menganalisis perbedaan pengaruh cognitive therapy dan logo therapy terhadap depresi pada pasien dengan hemodialisis. Penelitian ini menggunakan desain penelitian quasi experimental pre – post test design. Jumlah responden dalam penelitian ini 15 responden untuk kelompok cognitive therapy dan 15 responden untuk kelompok logo therapy yang didapatkan dengan menggunakan tehnik purposive sampling. Penelitian dilakukan di unit hemodialisis RS Wava Husada Kepanjen mulai tanggal 21 April – 26 Mei 2017. Pemberian terapi dilakukan oleh peneliti sendiri yang telah mendapatkan lisensi dari perawat spesialis jiwa. Analisis data yang digunakan dalam penelitian ini adalah dependent t test dan independent t test. Hasil analisis dependent t test  pada kelompok sebelum dan setelah diberikan cognitive therapy dan logo therapy didapatkan hasil nilai signifikansi 0,000 < 0,05 yang berarti bahwa ada perbedaan skor depresi antara sebelum dan sesudah diberikan pemberian cognitive therapy dan logo therapy  Sedangkan hasil analisis independent t test menunjukkan bahwa nilai signifikansi 0,000 < 0,05 yang berarti  ada perbedaan yang bermakna antara cognitive therapy dan logo therapy dalam menurunkan depresi pada pasien dengan hemodialisis yaitu dengan rata – rata penurunan terhadap depresi untuk cognitive therapy dan logo therapy masing – masing yaitu 1,62 dan 3,86.  Hal ini berarti bahwa logo therapy lebih efektif menurunkan depresi pada pasien hemodialisis dari pada cognitive therapy. Berdasarkan hasil penelitian tersebut diharapkan bahwa logo therapy bisa diaplikasikan sebagai alternatif psikoterapi pada pasien hemodialisis.Kata Kunci: cognitive therapy, logo therapy, depresi pada pasien hemodialisis


1989 ◽  
Vol 9 (3) ◽  
pp. 261-262 ◽  
Author(s):  
Alfred K. Cheung ◽  
Richard Brownley

Author(s):  
Nina Mann ◽  
Annemarie Fayemi ◽  
Melissa Myles ◽  
Nicole Kelley ◽  
Brian Carmine ◽  
...  
Keyword(s):  

Author(s):  
Nicholas North ◽  
Jessica Bishop ◽  
Dan Bruce ◽  
Timothy Boardman
Keyword(s):  

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Shahana Perveen ◽  
Karmaine A. Millington ◽  
Suchitra Acharya ◽  
Amit Grag ◽  
Vita Boyar

AbstractObjectivesTo describe challenges in diagnosis and treatment of congenital neonatal gangrene lesions associated with history of maternal coronavirus disease 2019 (COVID-19) infection.Case presentationA preterm neonate was born with upper extremity necrotic lesions and a history of active maternal COVID-19 infection. The etiology of his injury was challenging to deduce, despite extensive hypercoagulability work-up and biopsy of the lesion. Management, including partial forearm salvage and hand amputation is described.ConclusionsNeonatal gangrene has various etiologies, including compartment syndrome and intrauterine thromboembolic phenomena. Maternal COVID-19 can cause intrauterine thrombotic events and need to be considered in a differential diagnosis.


2021 ◽  
pp. 167-175
Author(s):  
Stephanie Munie ◽  
Pairach Pintavorn

Excessive intake of zinc is a known but often forgotten cause of copper deficiency, and its consequences in the context of end-stage renal disease (ESRD) are not widely discussed. Zinc-induced copper deficiency (ZICD) can result in erythropoietin (EPO)-resistant anemia and may not be considered as a possible etiology when conducting the work-up. We present a case wherein an ESRD patient had been receiving excess zinc for several months and subsequently experienced EPO-resistant anemia. Our patient’s GI work-up was negative, and increased doses of iron and EPO-stimulating agent were ineffective. She underwent a bone marrow biopsy and more serological testing. She was ultimately diagnosed with ZICD, and cessation of her zinc supplement and initiation of copper replacement proved effective in restoring EPO responsiveness. Awareness of ZICD as a possible factor in EPO-resistant anemia could lead to an expedited diagnosis and avoid an unnecessary and extensive work-up.


Nephron ◽  
2000 ◽  
Vol 86 (1) ◽  
pp. 96-98 ◽  
Author(s):  
Hiroko Wakasugi ◽  
Takahiro Futami ◽  
Eri Muso ◽  
Takahiko Ono ◽  
Shigetake Sasayama ◽  
...  
Keyword(s):  

2021 ◽  
pp. 112972982110008
Author(s):  
Joao Pedro Teixeira ◽  
Sara A Combs ◽  
Jonathan G Owen

Patients with end-stage kidney disease are at increased risk of death from coronavirus disease 2019 (COVID-19). In addition, severe COVID-19 has been associated with an increased risk of arterial and venous thromboses. In this report, we describe the case of a hemodialysis patient who developed an otherwise-unexplained thrombosis of an arteriovenous fistula during a symptomatic COVID-19 infection. Despite prompt treatment with three technically successful thrombectomies along with systemic intravenous heparin and two rounds of catheter-directed thrombolysis with tissue plasminogen activator, the fistula rapidly re-thrombosed each time and he required tunneled dialysis catheter placement. He subsequently required admission for hypoxemia from COVID-19 pneumonia and ultimately developed a catheter-related blood stream infection that likely contributed to his death. As the fistula had been previously well functioning and no angiographic explanation for the thrombosis was found, we speculate in this case the recurrent thromboses were related to the hypercoagulable state characteristic of severe COVID-19. Interventionalists performing hemodialysis access procedures should be aware of the prothrombotic state associated with COVID-19 and should consider it when deliberating how to best plan and approach access interventions in patients with symptomatic COVID-19.


Sign in / Sign up

Export Citation Format

Share Document